首页> 中文期刊> 《中国继续医学教育》 >米索前列醇预防中期妊娠引产后出血的临床观察

米索前列醇预防中期妊娠引产后出血的临床观察

         

摘要

目的 探讨米索前列醇对中期妊娠引产后出血的预防作用.方法 将2011年2月~2014年12月我院收治的98例中期妊娠引产产妇随机分为观察组和对照组,每组49例.对照组给予缩宫素治疗,观察组接受米索前列醇治疗.对比两组患者产后2 h、24 h出血量及出血率.结果治疗后观察组产后2 h、24 h出血量低于对照组,差异具有显著性(P<0.05);观察组产妇的出血率(2.04%)低于对照组产妇的出血率(12.24%),具有显著性差异(P<0.05).结论 米索前列醇对中期妊娠引产产后出血有较好的预防作用,可显著降低产后引产后的出血量及出血率.%Objective To investigate the preventive effect of misoprostol on bleeding after induction of labor in mid pregnancy. Methods 98 cases of the middle of 2011 February to 2014 December in our hospital were pregnancy induced labor were randomly divided into observation group and control group, 49 cases in each group. The control group was given oxytocin treatment, the observation group received misoprostol treatment. Compared two groups of patients with postpartum 2h, 24h amount of bleeding and bleeding rate. Results After the treatment, observation group after 2h, 24h amount of bleeding was significantly lower than the control group, the difference was significant (P < 0.05), the observation group maternal bleeding rate (2.04%) was significantly lower than the control group, maternal bleeding rate (12.24%), with significant difference (P < 0.05). Conclusion Misoprostol for induction of labor in mid pregnancy postpartum hemorrhage has better prevention effect, can significantly reduce the postpartum hemorrhage after induced abortion and bleeding rate.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号